$722 Million is the total value of Integral Health Asset Management, LLC's 65 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AMGN | New | AMGEN INC | $17,469,400 | – | 65,000 | +100.0% | 2.42% | – |
| BDX | New | BECTON DICKINSON & CO | $16,804,450 | – | 65,000 | +100.0% | 2.33% | – |
| DXCM | New | DEXCOM INC | $16,327,500 | – | 175,000 | +100.0% | 2.26% | – |
| MOH | New | MOLINA HEALTHCARE INC | $11,476,150 | – | 35,000 | +100.0% | 1.59% | – |
| AVTR | New | AVANTOR INC | $11,067,000 | – | 525,000 | +100.0% | 1.53% | – |
| NBIX | New | NEUROCRINE BIOSCIENCES INC | $9,562,500 | – | 85,000 | +100.0% | 1.32% | – |
| NTRA | New | NATERA INC | $8,850,000 | – | 200,000 | +100.0% | 1.22% | – |
| New | MOONLAKE IMMUNOTHERAPEUTICSput | $8,550,000 | – | 150,000 | +100.0% | 1.18% | – | |
| CTLT | New | CATALENT INC | $7,284,800 | – | 160,000 | +100.0% | 1.01% | – |
| BBIO | New | BRIDGEBIO PHARMA INC | $7,251,750 | – | 275,000 | +100.0% | 1.00% | – |
| PACB | New | PACIFIC BIOSCIENCES CALIF IN | $6,680,000 | – | 800,000 | +100.0% | 0.92% | – |
| New | SAREPTA THERAPEUTICS INCcall | $6,061,000 | – | 50,000 | +100.0% | 0.84% | – | |
| CRNX | New | CRINETICS PHARMACEUTICALS IN | $5,948,000 | – | 200,000 | +100.0% | 0.82% | – |
| WBA | New | WALGREENS BOOTS ALLIANCE INC | $5,560,000 | – | 250,000 | +100.0% | 0.77% | – |
| New | ROIVANT SCIENCES LTD | $5,256,000 | – | 450,000 | +100.0% | 0.73% | – | |
| MRK | New | MERCK & CO INC | $5,147,500 | – | 50,000 | +100.0% | 0.71% | – |
| CABA | New | CABALETTA BIO INC | $5,022,600 | – | 330,000 | +100.0% | 0.70% | – |
| PFE | New | PFIZER INC | $4,975,500 | – | 150,000 | +100.0% | 0.69% | – |
| ZTS | New | ZOETIS INCcl a | $3,479,600 | – | 20,000 | +100.0% | 0.48% | – |
| New | 89BIO INCcall | $3,088,000 | – | 200,000 | +100.0% | 0.43% | – | |
| WW | New | WW INTL INC | $2,767,500 | – | 250,000 | +100.0% | 0.38% | – |
| TNDM | New | TANDEM DIABETES CARE INC | $2,700,100 | – | 130,000 | +100.0% | 0.37% | – |
| BPMC | New | BLUEPRINT MEDICINES CORP | $2,511,000 | – | 50,000 | +100.0% | 0.35% | – |
| SILK | New | SILK RD MED INC | $2,248,500 | – | 150,000 | +100.0% | 0.31% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CYTOKINETICS INC | 15 | Q3 2023 | 4.7% |
| SAGE THERAPEUTICS INC | 15 | Q2 2023 | 5.0% |
| BIOMARIN PHARMACEUTICAL INC | 15 | Q2 2023 | 4.1% |
| ENVISTA HOLDINGS CORPORATION | 14 | Q3 2023 | 4.0% |
| AKERO THERAPEUTICS INC | 14 | Q3 2023 | 1.5% |
| REVVITY INC | 13 | Q3 2023 | 4.2% |
| BLUEPRINT MEDICINES CORP | 13 | Q3 2023 | 3.3% |
| PTC THERAPEUTICS INC | 13 | Q2 2023 | 1.7% |
| ELEVANCE HEALTH INC | 12 | Q3 2023 | 6.7% |
| NEVRO CORP | 12 | Q4 2022 | 4.5% |
View Integral Health Asset Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-09 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-03 |
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-02-02 |
| 13F-HR | 2021-11-12 |
View Integral Health Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.